Uterine sarcomas managed by surgery followed by radiation therapy. Clinical outcome, prognostic factors and role of radiation therapy;Les sarcomes uterins traites par chirugie et irradiation postoperatoire. Modes de rechute, facteurs pronostiques, role de la radiotherapie

Bulletin du Cancer

Volumn 84, Issue 6, 1997, Pages 625-629

  Coquard, Régis ^a   Romestaing, Pascale ^a   Ardiet, Jean Michel ^a   Mornex, Françoise ^a   Sentenac, Irénée ^a   Gérard, Jean Pierre ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Brachytherapy; Prognostic factors; Radiotherapy; Sarcomas; Uterine neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; VINCRISTINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOSARCOMA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; LUNG METASTASIS; MULTIVARIATE ANALYSIS; PERITONEUM METASTASIS; POSTMENOPAUSE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; UTERUS SARCOMA; UTERUS SURGERY; FRANCE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; SARCOMA; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FRANCE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIATION TOLERANCE; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0030741899     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schaffer P, Lavillaurex J. te cancer dans le Bas-Rhin. Paris : Édition Economica, 1981.
2. Calais G, Finot-Rousseau S, Body G, Fetissof F, Le Floch O, Lansac J. Sarcomes de l'endomètre. Épidémiologie et facteurs pronostiques. À propos d'une étude de 22 cas. J Gynecol Obstet Biol Reprod 1989 ; 18 : 885-9.
3. Schwartz Z, Dgani R, Lancet M, Kessler I. Uterine sarcoma in Israel : a study of 104 cases. Gynecol Oncol 1985 ; 20 : 354-63.
4. Piver MS, Lurain JR. Uterine sarcoma : clinical features and management. In : Coppleson M, ed. Gynecologic oncology. Vol II, Edinburgh : Churchill Livingstone, 1981 ; 591-607.
5. Chen SS. Propensivity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. Gynecol Oncol 1989 ; 32 : 215-7.
6. Peiffert D, Pernot M, Guillemin F, Luporsi E, Parache RM, Legras B, Bey P. Les tumeurs mixtes müllériennes de l'endomètre. Étude rétrospective, à visée pronostique, comparant leur évolution à celle des adénocarcinomes de l'endomètre. J Gynecol Obstet Biol Reprod 1991 ; 20 : 933-40.
7. Rose PG, Piver MS, Tsukuda Y, Lau T. Patterns of metastasis in uterine sarcoma. Cancer 1989 ; 63 : 935-8.
8. Spanos WJ, Peters LJ, Oswald MJ. Patterns of recurrence in malignant mixed mullerian tumor of the uterus. Cancer 1986 ; 57 : 155-9.
9. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL. Treatment of uterin leiomyosarcoma. Obstet Gynecol 1988 ; 71 : 845-50.
10. Dinh TV, Slavin RE, Bhagavan BS, Hannigan EV, Tiamson EM, Yandell RB. Mixed mullerian tumors of the uterus : a clinicopathological study. Obstet Gynecol 1989 ; 74 : 388-92.
11. Di Saia P, Castro JR, Rutledge FN. Mixed mesodermal sarcoma of the uterus. Radiology 1973 ; 117 : 632-6.
12. Echt G, Jepson J, Steel J, Langholz B, Luxton G, Hernandez W, et al. Treatment of uterine sarcomas. Cancer 1990 ; 66 : 35-9.
13. Vongtama R, Karler JR, Piver SM, Tsukuda Y, Moore RH. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri. Am J Roentgenol 1976 ; 126 : 139-47.
14. Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, Rudolph J. Uterine sarcomas. Natural history, treatment and prognosis. Cancer 1978 ; 42 : 1152-60.
15. Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, Rudolph J. Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 1978 ; 42 : 1161-70.
16. Larson B, Silfversward C, Nilsson B, Petterson F. Mixed mullerian tumours of the uterus-prognostic factors : a clinical and histopathologic study of 147 cases. Radiother Oncol 1990 ; 17 : 123-32.
17. Perez CA, Askin F, Baglan RJ, Kao MS, Kraus FT, Perez BM, et al. Effects of irradiation on mixed mullerian tumors of the uterus. Cancer 1979 ; 43 : 1274-84.
18. Belgrad R, Elbadawi N, Rubin P. Uterine sarcoma. Radiology 1975 ; 114 : 181-8.
19. Hornback NB, Omura G, Major FJ. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 1986 ; 12 : 2127-30.
20. Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcoma. A gynecologic Oncology Group study. J Clin Oncol 1985 ; 3 : 1240-5.
21. Piver MS, Lele SB, Marchetti DL, Emrich LJ. Effects of adjuvant chemotherapy on time to recurrence and survival in stage I uterine sarcoma. J Surg Oncol 1988 ; 38 : 233-9.
22. Olah KS, Gee H, Blunt JA, Kelly K, Chan KK. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 1991 ; 27 (9) : 1095-9.
23. Kahanpaa KV, Wahlstrom T, Grohn P, Heinonen E, Nieminen U, Widholm O. Sarcoma of the uterus : a clinicopathological study of 119 patients. Obstet Gynecol 1986 ; 67 : 417-24.
24. Wheelock JB, Krebs HB, Schneider V, Goplerud DR. Uterine sarcomas : analysis of prognostic variables in 71 cases. Am J Obstet Gynecol 1985 ; 151 : 1016-22.
25. Wolfson AH, Wofson DJ, Sittler SY, Breton L, Markoe AM, Schwade JG, et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 1994 ; 52 : 56-62.
26. UICC. TNM atlas of malignant tumours. Frankfurt : Springer Verlag, 1992.
27. Michel G, Pfeiffer F, Duvillard P, Prade M, Castaigne D, Zarca D, et al. Sarcomes utérins. Étude clinique à propos de 50 cas opérés à l'Institut Gustave-Roussy. Revue de la littérature. J Gynecol Obstet Biol Reprod 1989 ; 18 : 1024-30.
28. Doss LL, Llorens AS, Henriquez EM. Carcinosarcoma of the uterus : a 40-year experience from the state of Missouri. Gynecol Oncol 1984 ; 18 : 43-53.
29. George M, Pejovic MH, Kramar A and the Gynecologic Cooperative Group of French Oncology Centers. Uterine sarcomas : prognostic factors and treatment modalities-study on 209 patients. Gynecol Oncol 1986 ; 24 : 58-67.